Market Cap 66.63M
Revenue (ttm) 0.00
Net Income (ttm) -102.33M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.16
Volume 196,900
Avg Vol 230,822
Day's Range N/A - N/A
Shares Out 60.57M
Stochastic %K 13%
Beta 0.03
Analysts Strong Sell
Price Target $9.20

Latest News on ABOS

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

Oct 15, 2024, 8:00 AM EDT - 6 months ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

LENZ


Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024

Sep 25, 2024, 4:00 PM EDT - 6 months ago

Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024


Navigating Acumen's Alzheimer's Risk And Reward

Oct 3, 2023, 11:03 AM EDT - 1 year ago

Navigating Acumen's Alzheimer's Risk And Reward